Sale!

CEP152 Gene Microcephaly Autosomal Recessive Type 9 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The “CEP152 Gene Microcephaly Autosomal Recessive Type 9 Genetic Test” is a specialized diagnostic procedure aimed at identifying mutations in the CEP152 gene, which are linked to Microcephaly Autosomal Recessive Type 9. This condition is a rare genetic disorder characterized by significantly reduced head size (microcephaly) and brain development issues, which can lead to developmental delays and neurological problems. The test is crucial for families with a history of the condition or for parents who may be carriers of the gene mutation, offering them valuable insights into their genetic makeup and the risk of passing the condition onto their children.

Performed at DNA Labs UAE, a leading facility in genetic testing, the test involves collecting a DNA sample, typically through a blood draw or cheek swab, and analyzing it for specific mutations in the CEP152 gene. The cost of the test is 4400 AED, reflecting the specialized nature of the genetic analysis and the detailed, personalized report provided to the patient or the family. This test is not only pivotal for diagnosis but also plays a crucial role in guiding the management and treatment of individuals with the condition, offering families the necessary information to make informed healthcare decisions.

Description

CEP152 Gene Microcephaly autosomal recessive type 9 Genetic Test

Components: CEP152 Gene Microcephaly autosomal recessive type 9 Genetic Test

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Dysmorphology

Doctor: Pediatrics

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for CEP152 Gene Microcephaly, autosomal recessive type 9 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with CEP152 Gene Microcephaly, autosomal recessive type 9 NGS Genetic DNA Test gene CEP152

Test Details: CEP152 (Centrosomal Protein 152) is a gene that plays a crucial role in cell division and the formation of centrosomes, which are important for organizing the microtubules that help cells divide. Mutations in the CEP152 gene have been associated with a form of microcephaly known as autosomal recessive type 9 (MCPH9). Microcephaly is a condition characterized by a smaller than average head size and reduced brain growth. In the case of MCPH9, individuals typically have severe microcephaly, intellectual disability, and developmental delays. Other features may include facial abnormalities, short stature, and seizures.

NGS (Next-Generation Sequencing) genetic testing is a method used to analyze the DNA sequence of genes, including the CEP152 gene, to identify any mutations or variants that may be present. This type of testing can help in diagnosing genetic conditions, such as MCPH9, by identifying specific genetic changes that may be causing the symptoms. If a person is suspected to have MCPH9, a geneticist or other healthcare professional may recommend NGS genetic testing to confirm the diagnosis. This involves collecting a sample of the person’s DNA, usually through a blood or saliva sample, and sending it to a laboratory for analysis. The laboratory will use NGS technology to sequence the DNA and look for any mutations or variants in the CEP152 gene.

The results of the NGS genetic test can provide valuable information for diagnosis, prognosis, and potential treatment options. It can also help in providing genetic counseling to the individual and their family members regarding the inheritance and recurrence risks of MCPH9. It is important to note that genetic testing should always be done under the guidance of a healthcare professional, who can help interpret the results and provide appropriate support and guidance.

Test Name	CEP152 Gene Microcephaly autosomal recessive type 9 Genetic Test
Components
Price	4400.0 AED
Sample Condition	Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery	3 to 4 Weeks
Method	NGS Technology
Test type	Dysmorphology
Doctor	Pediatrics
Test Department:	Genetics
Pre Test Information	Clinical History of Patient who is going for CEP152 Gene Microcephaly, autosomal recessive type 9 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with CEP152 Gene Microcephaly, autosomal recessive type 9 NGS Genetic DNA Test gene CEP152
Test Details	CEP152 (Centrosomal Protein 152) is a gene that plays a crucial role in cell division and the formation of centrosomes, which are important for organizing the microtubules that help cells divide. Mutations in the CEP152 gene have been associated with a form of microcephaly known as autosomal recessive type 9 (MCPH9). Microcephaly is a condition characterized by a smaller than average head size and reduced brain growth. In the case of MCPH9, individuals typically have severe microcephaly, intellectual disability, and developmental delays. Other features may include facial abnormalities, short stature, and seizures. NGS (Next-Generation Sequencing) genetic testing is a method used to analyze the DNA sequence of genes, including the CEP152 gene, to identify any mutations or variants that may be present. This type of testing can help in diagnosing genetic conditions, such as MCPH9, by identifying specific genetic changes that may be causing the symptoms. If a person is suspected to have MCPH9, a geneticist or other healthcare professional may recommend NGS genetic testing to confirm the diagnosis. This involves collecting a sample of the person’s DNA, usually through a blood or saliva sample, and sending it to a laboratory for analysis. The laboratory will use NGS technology to sequence the DNA and look for any mutations or variants in the CEP152 gene. The results of the NGS genetic test can provide valuable information for diagnosis, prognosis, and potential treatment options. It can also help in providing genetic counseling to the individual and their family members regarding the inheritance and recurrence risks of MCPH9. It is important to note that genetic testing should always be done under the guidance of a healthcare professional, who can help interpret the results and provide appropriate support and guidance.